Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples